Institutions / Ifrah Financial Services, Inc.

Ifrah Financial Services, Inc.

CIK 1382646 · Institution · as of Mar 31, 2026
Portfolio value
$378.28M
Positions
200
As of
Mar 31, 2026

Portfolio trend

Portfolio value

$378.28M-2.8%
$389.36M$383.82M$378.28MQ4 '25Q1 '26

Positions

200-4.3%
209205200Q4 '25Q1 '26

Top holdings

Mar 31, 2026View all 200 →
CompanyClassValueShares% of portfolio
iShares Tr$26.12M515,8486.9%
iShares Tr$19.11M168,9575.1%
Apple Inc.$17.65M69,5654.7%
iShares Tr$14.26M172,6423.8%
iShares Tr$14.15M140,6693.7%
Vanguard Intl Equity Index F$12.00M159,8163.2%
Janus Detroit Str Tr$9.98M198,1882.6%
iShares Tr$9.37M183,9862.5%
iShares U S ETF Tr$9.11M179,1222.4%
iShares Tr$8.95M114,2022.4%
Vanguard Index Fds$8.51M39,1632.2%
First Tr Exchange-Traded Fd$7.79M130,3732.1%
iShares Tr$7.76M65,5082.1%
iShares Tr$7.64M52,7912.0%
Vanguard Index Fds$7.10M23,4951.9%
iShares Tr$6.72M133,1181.8%
Schwab Strategic Tr$6.54M214,4151.7%
PGIM ETF Tr$6.54M132,0581.7%
Schwab Strategic Tr$6.51M133,1461.7%
iShares Tr$6.18M145,4891.6%
Vanguard Index Fds$5.58M18,6761.5%
iShares Tr$5.56M89,7671.5%
iShares MSCI UAE ETF$5.20M39,2791.4%
Vanguard World Fd$4.48M12,1981.2%
Direxion Shares ETF Trust$3.99M118,8601.1%

Activity

InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
DateActionCompanyValueShares ΔPosition afterImpact
Q1 2026
as of
Trim46429B655
Common stock
$-1.88M-37K
-16.71%
183,986
2.48% of portfolio
low
Q1 2026
as of
Add464287457
Common stock
$1.69M+20K
+13.47%
172,642
3.77% of portfolio
low
Q1 2026
as of
Trim46434V100
Common stock
$-1.69M-33K
-20.05%
133,118
1.78% of portfolio
low
Q1 2026
as of
TrimApple Inc.
Common stock
$-1.51M-6K
-7.86%
69,565
4.67% of portfolio
low
Q1 2026
as of
New92206C706
Common stock
$1.38M+23K
23,111
0.36% of portfolio
low
Q1 2026
as of
Trim46431W507
Common stock
$-1.01M-20K
-10.01%
179,122
2.41% of portfolio
low
Q1 2026
as of
ExitAlphabet Inc.
Common stock
$-764.8K-2K
-100.00%
0
low
Q1 2026
as of
Add464288646
Common stock
$756.3K+14K
+33.74%
57,041
0.79% of portfolio
low
Q1 2026
as of
Trim922042775
Common stock
$-480.9K-6K
-3.85%
159,816
3.17% of portfolio
low
Q1 2026
as of
NewHalozyme Therapeutics Inc
Common stock
$454.3K+7K
7,029
0.12% of portfolio
low